T8S-11061-35487
3 vaccinations
2 coded responses
39 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 500 / IA
- Registered
- 2021-06-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-03
Dose 1 — Pfizer-BioNTech
-
2021-06-04
Registered in v-safe
-
2021-06-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-06-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-06-07
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-17
-
2021-06-24
Dose 2 — Pfizer-BioNTech
- 2021-06-24
-
2021-06-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Chills, Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-06-26
- 2021-06-27
- 2021-06-28
- 2021-06-29
- 2021-06-30
- 2021-07-01
- 2021-07-08
- 2021-07-15
- 2021-07-22
- 2021-07-29
- 2021-08-05
- 2021-09-23
- 2021-12-24
-
2021-12-30
Dose 3 — Pfizer-BioNTech
- 2021-12-30
-
2021-12-31
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
-
2022-01-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-01-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2022-01-04
- 2022-01-05
- 2022-01-07
-
2022-01-13
Survey response — day 14, dose 3MedDRA: Dyspnoea — Feeling: FairFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-02-10
- 2022-03-31
-
2022-06-30
Survey response — 6 months, dose 3MedDRA: Bacterial infection, Chills, Cough, Fatigue, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Sinusitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Starting the day of my positive CoVid test, I had a fever for 4 days (up to 101*F) with some chills. Additionally, I had fatigue, a sore throat and cough, and a bacterial sinus infection that followed once many other symptoms had improved.MedDRA releases: 2024-11 · check-in free text available
- 2022-12-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-03 | Pfizer-BioNTech | |
| 2 | 2021-06-24 | Pfizer-BioNTech | No |
| 3 | 2021-12-30 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 3
Symptoms: Shortness of breath
Release 12 — 6 months, dose 3
Symptoms: Starting the day of my positive CoVid test, I had a fever for 4 days (up to 101*F) with some chills. Additionally, I had fatigue, a sore throat and cough, and a bacterial sinus infection that followed once many other symptoms had improved.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bacterial infection | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release